Evidence map›Paper›PMID 35044824›Full record

ArticleScience advances2022

Up-regulation of proBDNF/p75

Wei-Yun Shen, Cong Luo, Plinio Reinaldo Hurtado, Xiao-Jing Liu, Ru-Yi Luo, Hui Li, Zhao-Lan Hu, Jun-Mei Xu, Elizabeth J Coulson, Ming Zhao and 2 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. P75iScience · 2025
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Expression of proBDNF/p75Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Up-Regulation of ProBDNF/p75Journal of inflammation research · 2023
    Article
  17. Article
  18. proBDNF blockade modulates SLE.Nature reviews. Rheumatology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Wei-Yun ShenDepartment of Anesthesiology, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.ORCID 0000-0003-2960-7319
Cong LuoDepartment of Anesthesiology, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.ORCID 0000-0002-5159-8343
Plinio Reinaldo HurtadoDepartment of Renal Medicine, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.ORCID 0000-0002-0913-7797
Xiao-Jing LiuDepartment of Anesthesiology, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.
Ru-Yi LuoDepartment of Anesthesiology, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.
Hui LiDepartment of Anesthesiology, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.ORCID 0000-0002-0959-455X
Zhao-Lan HuDepartment of Anesthesiology, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.
Jun-Mei XuDepartment of Anesthesiology, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.
Elizabeth J CoulsonQueensland Brain Institute, The University of Queensland, 4072 Brisbane, Australia.ORCID 0000-0003-3783-6197
Ming ZhaoDepartment of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.
Xin-Fu ZhouSchool of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide, SA 5000, Australia.ORCID 0000-0002-8687-0175
Ru-Ping DaiDepartment of Anesthesiology, The Second Xiangya Hospital, Central South University, 139 Ren-Min Central Road, Changsha City, Hunan 410011, China.ORCID 0000-0002-1027-6698
Central South University · CNRoyal Adelaide Hospital · AUThe University of Queensland · AUUniversity of South Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inappropriate expansion of antibody-secreting cells (ASCs) is typical of systemic lupus erythematosus (SLE), but the regulatory signaling of pathogenic ASCs is unclear. The present study shows that brain-derived neurotrophic factor precursor (proBDNF) and its high-affinity pan-75 neurotrophin receptor (p75

Indexed as

Lupus Erythematosus, SystemicReceptors, Nerve Growth FactorAnimalsAntigens, CD19AutoantibodiesB-LymphocytesBrain-Derived Neurotrophic FactorHumansMiceMice, Inbred C57BLUp-RegulationAntigens, CD19AutoantibodiesBdnf protein, mouseBrain-Derived Neurotrophic FactorReceptors, Nerve Growth Factor

Identifiers

PMID35044824
PMCPMC8769540
OpenAlexW4205652616

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.